The FASEB Journal, Vol 9, 446-452, Copyright © 1995 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat

RA Dela Cadena, A Stadnicki, AB Uknis, RB Sartor, CA Kettner, A Adam and RW Colman
Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

We investigate whether the previously shown contact system activation plays a pathogenetic role in a rat model of acute inflammation induced by peptidoglycan-polysaccharide (PG-APS) using a new specific plasma kallikrein inhibitor, Bz-Pro-Phe-boroArg-OH (P8720). Group I (control) received neither PG-APS nor inhibitor. Group II (disease-treated) received PG-APS intraperitoneally (IP) and P8720 orally. Group III (disease-untreated) received PG-APS IP. Anemia was evident at 49 h in group III but was not present (P < 0.01) in groups I and II. Spleen weight was significantly decreased in group II compared to group III. Acute arthritis progressively developed in group III from 27 to 49 h, but P8720 decreased the joint swelling in group II by 61% (P < 0.0005). We observed a significant fall in prekallikrein and factor XI (P < 0.01) in groups II and III but not in group I. The decrease in the functional levels of high molecular weight kininogen (P < 0.05) observed in group III were prevented by P8720 in group II. The changes in T-kininogen and alpha 1-inhibitor 3 acute-phase proteins were partially prevented by P8720. We conclude that the inflammatory reactions leading to arthritis and anemia, as well as the acute-phase reaction, are due in part to contact activation, and that specific kallikrein inhibitors may have therapeutic potential.

This article has been cited by other articles:

				M. M. Khan, H. N. Bradford, I. Isordia-Salas, Y. Liu, Y. Wu, R. G. Espinola, B. Ghebrehiwet, and R. W. Colman High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2260 - 2266. [Abstract] [Full Text] [PDF]

				D Wong Auditing cataract surgery nationwide Br. J. Ophthalmol., July 1, 2006; 90(7): 817 - 817. [Full Text] [PDF]

				I. Isordia-Salas, R. A. Pixley, H. Parekh, S. P. Kunapuli, F. Li, A. Stadnicki, Y. Lin, R. B. Sartor, and R. W. Colman The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation Blood, October 15, 2003; 102(8): 2835 - 2842. [Abstract] [Full Text] [PDF]

				A. Stadnicki, R. B. Sartor, R. Janardham, A. Majluf-Cruz, C. A. Kettner, A. A. Adam, and R. W. Colman Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats FASEB J, March 1, 1998; 12(3): 325 - 333. [Abstract] [Full Text]

				R. W. Colman and A. H. Schmaier Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes Blood, November 15, 1997; 90(10): 3819 - 3843. [Full Text] [PDF]